By Leah Douglas and Siddhi Mahatole Feb 6 (Reuters) - The U.S. Food and Drug Administration said on Friday it would take ...

Hims & Hers (NYSE:HIMS) shares are plunging 16% in after-hours trading following coordinated moves by two federal agencies ...

FDA Moves to Restrict Compounding GLP-1 Ingredients ...

Compounding pharmacies are facilities that are able to make customized medications. This could be to alter a drug's dosage or composition for medical purposes. Many patients have benefitted from drug ...

Legislative sessions are underway in most states, and some have introduced novel legislation to regulate compounded ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

Following escalating legal threats from federal regulators regarding plans to sell an unapproved form of Novo Nordisk’s Wegovy pill, Hims said it “decided to stop offering access” to the treatment.

Hims Hers Health announced on Saturday that it will stop offering access to its compounded semaglutide pill following a ...

By Carlos Méndez and Chris Thomas Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action ...

Compounding drugs prior to receipt of a valid prescription. Compounding drugs removed from the market for safety reasons. Compounding drugs that are essentially copies of commercially available ...